Connect with us

Coronavirus Outbreak

May Need COVID-19 Vaccine Booster Shots For Emerging Variants Of Novel Coronavirus: AIIMS Chief

AIIMS Chief Dr Randeep Guleria said that once the population is vaccinated against COVID-19, then the next step will be to administer a booster dose

May Need COVID-19 Vaccine Booster Shots For Emerging Variants Of Novel Coronavirus AIIMS Chief
Highlights
  • By September vaccines should be available for children: Dr Randeep Guleria
  • Booster dose will be a second-generation vaccine, said Dr Guleria
  • Second-generation vaccines would be better in terms of the immunity

New Delhi: With various mutations of the SARS-CoV-2 emerging in the near future, there might be a need for the country to adopt a booster dose with second-generation COVID-19 vaccines, said All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria. “It seems that we probably need the booster dose of vaccines as with the passage of time the immunity tends to fall. There is waning immunity. We would like to have booster dose that will cover for various emerging variants,” Dr Guleria said in an interview with ANI.

Also Read: Study Shows Why Second Dose Of COVID-19 Vaccine Should Not Be Skipped

He further stated that the booster dose will be a second-generation vaccine.

We will have second-generation vaccines which would be better in terms of the immunity they give, covering of the new variants and a having a better overall efficacy. Trials of booster vaccine shots are already going on. You will probably need a booster dose till the end of this year. But that’s only once the population is vaccinated, then the next step will be to administer a booster dose, Dr Guleria said.

Bharat Biotech’s Covaxin trials for children are presently underway and the results are expected to be released by September, the AIIMS director informed.

The vaccines for children should come out now because trials in India are already there in the vaccines which are available in India, Bharat Biotech trial is in the final phase by September we will have the data, he said.

Also Read: Those Who Get Jabbed Become ‘Baahubali’; Over 40 Crore People Vaccinated Against COVID: PM Modi

The trial is conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12-18 years followed by the age group of 6-12 years and 2-6 years which are currently undergoing trials. He further said that Zydus Cadila has included the data for children for their COVID-19 vaccine.

Zydus Cadila vaccine has also included children and their data is already there. They have already applied for the emergency use authorization, he said.

Zydus Cadila has concluded its trial for children between the age group of 12 to 18. The Ahmedabad-based pharmaceutical firm had on July 1, requested emergency use approval for ZyCoV-D, its three-dose COVID shot – the world’s first Plasmid DNA vaccine.

It will, however, be a few more days before the country’s drug regulator Drugs Controller General of India (DCGI) gives it emergency use authorisation, as per sources. Dr Guleria also said,

In the coming few weeks or by September vaccines should be available for children. We should then start schools in a graded manner as we have been doing for 18-45 years age and that also will give more protection to kid and more confidence to public that children are safe.

Also Read: Coronavirus Explained: All About Zydus Cadila’s Needle Free COVID-19 Vaccine, ZyCoV-D

The Government of India has been holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer, for procuring their vaccine. However, there has been a delay over the same.

There could be multiple reasons of delay. I think two or three things need to be kept in mind. One is collaboration and the understanding with the government on the doses. But they should also have that many doses to give because we must understand that these companies have pre-booked the order from many countries. Thus, they have obligation to give vaccines to those countries. Unless they fulfill the obligations, they cannot spare doses for other countries like India and other parts of the world. They have huge pre-booked doses, explained the AIIMS chief.

India has been in discussions with the two firms on several issues including indemnity waiver. Earlier, Dr V K Paul, Member (Health), NITI Aayog had said,

We are holding discussions. It is a process of negotiation and dialogues. We are trying to get a solution on contractual and commitments issues. This process is ongoing.

Also Read: Entire Adult Population In India Will Be Vaccinated Against COVID-19 By December: Dr NK Arora, Head, Expert Panel On Immunisation

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

World

24,06,78,961Cases
20,23,40,977Active
3,34,39,331Recovered
48,98,653Deaths
Coronavirus has spread to 195 countries. The total confirmed cases worldwide are 24,06,78,961 and 48,98,653 have died; 20,23,40,977 are active cases and 3,34,39,331 have recovered as on October 18, 2021 at 4:17 am.

India

3,40,81,315 13,596Cases
1,89,6946,152Active
3,34,39,331 19,582Recovered
4,52,290 166Deaths
In India, there are 3,40,81,315 confirmed cases including 4,52,290 deaths. The number of active cases is 1,89,694 and 3,34,39,331 have recovered as on October 18, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

65,91,697 1,715

32,230 994

64,19,678 2,680

1,39,789 29

Kerala

48,54,321 7,555

88,186 3,292

47,39,270 10,773

26,865 74

Karnataka

29,83,459 326

9,479 58

29,36,039 380

37,941 4

Tamil Nadu

26,87,092 1,218

14,814 208

26,36,379 1,411

35,899 15

Andhra Pradesh

20,60,472 432

6,034 159

20,40,131 586

14,307 5

Uttar Pradesh

17,10,028 9

119 10

16,87,011 19

22,898

West Bengal

15,80,530 624

7,421 24

15,54,132 634

18,977 14

Delhi

14,39,390 32

320 6

14,13,981 38

25,089

Odisha

10,35,077 443

4,542 68

10,22,250 508

8,285 3

Chhattisgarh

10,05,654 16

183 2

9,91,901 14

13,570

Rajasthan

9,54,390 2

42 2

9,45,394 4

8,954

Gujarat

8,26,290 10

207 6

8,15,997 16

10,086

Madhya Pradesh

7,92,684 5

84 12

7,82,077 17

10,523

Haryana

7,71,076 15

123 9

7,60,904 6

10,049

Bihar

7,26,026 5

48 4

7,16,317 1

9,661

Telangana

6,68,955 122

3,924 55

6,61,093 176

3,938 1

Assam

6,06,468 205

3,436 46

5,97,082 245

5,950 6

Punjab

6,02,035 27

227 8

5,85,264 16

16,544 3

Jharkhand

3,48,430 7

122 1

3,43,173 8

5,135

Uttarakhand

3,43,756 9

178 1

3,36,181 8

7,397

Jammu And Kashmir

3,31,062 95

843 12

3,25,793 107

4,426

Himachal Pradesh

2,21,437 131

1,303 5

2,16,414 125

3,720 1

Goa

1,77,522 60

604 6

1,73,572 62

3,346 4

Puducherry

1,27,396 52

585 13

1,24,961 64

1,850 1

Manipur

1,22,737 104

1,422 0

1,19,418 102

1,897 2

Mizoram

1,12,848 249

11,633 1,143

1,00,829 1,389

386 3

Tripura

84,321 16

104 4

83,401 12

816

Meghalaya

82,953 55

845 32

80,673 86

1,435 1

Chandigarh

65,302 3

25 3

64,457 6

820

Arunachal Pradesh

54,987 7

140 30

54,567 37

280

Sikkim

31,749 4

174 8

31,184 12

391

Nagaland

31,611 40

248 12

30,689 28

674

Ladakh

20,878 2

36 10

20,634 12

208

Dadra And Nagar Haveli

10,676 1

4 1

10,668

4

Lakshadweep

10,365

0 0

10,314

51

Andaman And Nicobar Islands

7,641

9 0

7,503

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Highlights From The 12-Hour Telethon

Leaving No One Behind

Mental Health

Environment

Join Us